Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Eye Diseases Clinical Trials

9 recruiting trials for Eye Diseases. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
9
Total Trials
9
Recruiting Now
2
Phase 3 Trials
9
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT07174687

SGLT2 Inhibitors in Geographic Atrophy

AMD is a leading cause of blindness in individuals over 50 years old, with dry AMD being the most common form. Geographic atrophy (GA) is an advanced stage of dry AMD...

Sponsor: Washington University School of MedicineEnrolling: 701 location
RECRUITINGPhase 1 / Phase 2NCT06394232

Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

The goal of this clinical study is to evaluate the safety and efficacy of novel stem cell formulation in patients having Geographic Atrophy (GA) Secondary to Dry Age-related...

Sponsor: Eyestem Research Pvt. Ltd.Enrolling: 543 locations
RECRUITINGPhase 3NCT04663750

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to...

The centre of the retina (macula) at the back of the eye contains cells that give us our central vision that we use for reading and recognising faces. These cells can be damaged...

Sponsor: King's College Hospital NHS TrustEnrolling: 21020 locations
RECRUITINGNCT06934577

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the...

Sponsor: University of MichiganEnrolling: 9001 location
RECRUITINGPhase 1NCT05147701

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

This trial will study the safety and efficacy of intravenous and sub-tenon delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of...

Sponsor: The Foundation for Orthopaedics and Regenerative MedicineEnrolling: 202 locations
RECRUITINGPhase 4NCT07266948

Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work

This 1-month, 3-visit study will be conducted at the Southern College of Optometry (Memphis, TN), Kannarr Eye Care, LLC (Pittsburg, KS) and Complete Eye Care of Medina...

Sponsor: Southern College of OptometryEnrolling: 403 locations
RECRUITINGNCT07228793

Natural History Study of Patients With EYS-Associated RP

This natural history study of patients with EYS mutations from Russia and former CIS (Commonwealth of Independent States) territories will accelerate the development of outcome...

Sponsor: Sensor Technology for DeafblindEnrolling: 451 location
RECRUITINGPhase 1NCT06455826

MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

A Phase 1 Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31...

Sponsor: PYC TherapeuticsEnrolling: 125 locations
RECRUITINGPhase 3NCT06601101

Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus

The cornea plays a fundamental role in vision, being a complex tissue essential for ocular health. In ophthalmological practice, there are situations such as corneal crosslinking,...

Sponsor: University of Campinas, BrazilEnrolling: 361 location